Adapted Physical Activity for People with Lower Limb Peripheral Artery Disease
Official title: Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease (ACTIV'AO)
Run by Centre Hospitalier le Mans · NCT04800276 · Data updated 2026-11-12
This study tests a targeted exercise program to improve walking ability in people with peripheral artery disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Centre Hospitalier le Mans Academic / other |
| Locations | 1 site (Le Mans) |
| Status | Recruiting |
| Started | February 11, 2021 |
| Main results expected | November 11, 2026 |
| Study ends | November 11, 2026 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT04800276 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with lower limb peripheral arterial disease and intermittent claudication, with no contraindication to physical activity, able to consent.
✕Probably not a fit
Patients with non-ischemic leg pain, significant comorbid conditions limiting exercise, or those who do not respond to exercise therapy may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial aims to determine how muscle strengthening focused on ischemic areas, combined with global muscle strengthening, affects physical capacity in individuals with lower limb peripheral arterial disease and intermittent claudication. Participants have validated lower limb arterial disease, limited walking ability, and no contraindication to exercise, and they undergo an adapted exercise regimen. Outcomes focus on how ischemia-related pain patterns influence walking performance and muscle activity. The study explores whether tailoring the training to ischemic regions improves functional outcomes compared with standard approaches. Relevance is to better understand how biomechanics and ischemia location relate to rehabilitation potential.
Why it matters
Potential benefit: If successful, patients may experience improved walking distance and reduced claudication pain through a customized exercise program.
How similar studies have gone: Prior research supports exercise-based rehabilitation for peripheral arterial disease, though this specific ischemia-area–targeted approach is novel/less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with Lower Limb Peripheral Arterial Disease with IPSC \< 0.90, arterial stenosis in the lower limbs and intermittent claudication * No contraindication to physical activity * Socially insured patients over 18 ; * Patient who has signed the consent form. Exclusion Criteria: * Severe or unstable cardiopulmonary pathologies, contraindicating exercise training * Unstable angina or myocardial infarction \<3 months * Severe rheumatological pathology of the lower limbs * Amputee of a lower or upper limb fitted with a device * Extensive dermatosis of the lower limbs * Known NYHA grade III or IV heart failure * Known severe respiratory pathology * Parkinson's disease, hemiplegia or paraplegia * Adults subject to enhanced protection, deprived of their liberty by judicial or administrative decision * Persons unable to consent * Be in a period of exclusion from other interventional research. * Any event (injury, surgery, etc.) occurring during the protocol period that could have an impact on results.
Where it's running
-
Centre Hospitalier Du Mans
Le Mans, France Recruiting
Study contacts
- Study coordinator: Christelle JADEAU
- Email: cjadeau@ch-lemans.fr
- Phone: 02 44 71 07 81
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Predictors of Major Adverse Limb Events After Iliac Artery Stenting
This study tests what factors predict serious limb-related problems after iliac artery stenting in adults with peripheral artery disease.
-
New prodrug CG-0255 Besylate vs Plavix in healthy adults
This study tests whether CG-0255 Besylate works similarly to Plavix® in healthy adults to understand how the two drugs behave in the body.
-
Radial and Ulnar Access in Vascular Interventions Registry
This registry tests how often radial or ulnar artery access is used and what happens afterward in routine vascular procedures.
-
Remote versus in-person 30-second sit-to-stand testing for people with peripheral artery disease
This project will test whether doing the 30-second sit-to-stand test by video works as well as doing it in person for adults aged 18–65 with Fontaine stage I–II peripheral artery disease who have a smartphone.
-
Imaging plaque activity across the body in people with symptomatic peripheral arterial disease
This project will use whole-body PET-CT and CT angiography with several tracers to see if imaging can detect inflammation, microcalcification, and clot activity in people with symptomatic peripheral arterial disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.